Feasibility and Effectiveness of a Pilot Program of Physical Activity to Improve HIV Related Functional Limitations and Disability in Adults Aged 40 and Older From Côte d'Ivoire
- Disease/Condition
- HIV Infections
- Drug/Device/Intervention
- Quantitative research
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- ANRS, Emerging Infectious Diseases
- Location
- Abidjan,Abidjan, Côte D'Ivoire
- Phase
- N/A
- Start date
- Oct 31, 2023
- End date
- Apr 01, 2024
- Enrollment
- 450 participants
Performance at the 6' step-up test,Performance at the 6' walking test,Performances at the 5 stand-up and sit test,Performances at the Y balance Test,Grip strenght,Short Physical Performance Battery (SPPB) score,Scores of the Neuroscreen app tests,WHO Disability Assessment Schedule - 2.0 (WHODAS) score,HIV Disability Questionnaire - short form (HDQ-SF) score
The goal of this interventional study is to document the importance of HIV-related
 disabilities, notably the frequency / nature of functional limitations, neurocognitive
 impairments, and restrictions of social participation in adults living with HIV aged 40 and
 older.
 
 Participants will undergo a comprehensive set of cognitive and functional assessments, and
 approximately twenty particpants will be asked to participate in an anthropological survey
 conducted through structured interviews.
 
 Researchers will a group of people living with HIV and o reference group without HIV
 infection.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06139497
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06139497 through Pure Global AI's free database. This phase not specified trial is sponsored by ANRS, Emerging Infectious Diseases and is currently Recruiting. The study focuses on HIV Infections. Target enrollment is 450 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.